Glenmark Pharmaceuticals Limited (NSE:GLENMARK)
India · Delayed Price · Currency is INR 2,214.50
+9.40 (0.43%)
Jul 24, 2026, 3:29 PM IST
Glenmark Pharmaceuticals Market Cap
Glenmark Pharmaceuticals has a market cap or net worth of 618.58 billion as of July 24, 2026. Its market cap has increased by 2.49% in one year.
Market Cap
618.58B
Enterprise Value
612.75B
Revenue
169.83B
Ranking
n/a
PE Ratio
45.44
Stock Price
2,214.50
ChartMarket Cap Chart
Since June 7, 2001, Glenmark Pharmaceuticals's market cap has increased from 1.15B to 618.58B, an increase of 53,722.54%. That is a compound annual growth rate of 28.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 618.58B | 7.70% |
| Dec 31, 2025 | 574.34B | 26.49% |
| Dec 31, 2024 | 454.07B | 88.44% |
| Dec 29, 2023 | 240.96B | 101.33% |
| Dec 30, 2022 | 119.68B | -19.75% |
| Dec 31, 2021 | 149.14B | 7.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.14T |
| Zydus Lifesciences | 1.11T |
| Mankind Pharma | 1.04T |
| Aurobindo Pharma | 881.48B |
| Laurus Labs | 864.42B |
| Alkem Laboratories | 673.48B |
| Ipca Laboratories | 447.20B |
| Ajanta Pharma | 420.81B |